ARVINAS, INC. (ARVN) reporting calendar
ARVINAS, INC. files periodic reports with the SEC as ARVN on Nasdaq. Atlas tracks 31 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 24 Jul 2026 – 17 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 11 May 2026
- Reports on record
- 31
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 36 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open ARVN market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 11 May 2026 | 41 days | 0001628280-26-033669 |
| 10-K | 31 Dec 2025 | 24 Feb 2026 | 55 days | 0001628280-26-011226 |
| 10-Q | 30 Sep 2025 | 5 Nov 2025 | 36 days | 0001628280-25-049527 |
| 10-Q | 30 Jun 2025 | 6 Aug 2025 | 37 days | 0001655759-25-000139 |
| 10-Q | 31 Mar 2025 | 1 May 2025 | 31 days | 0001655759-25-000085 |
| 10-K | 31 Dec 2024 | 11 Feb 2025 | 42 days | 0001655759-25-000016 |
| 10-Q | 30 Sep 2024 | 30 Oct 2024 | 30 days | 0001655759-24-000131 |
| 10-Q | 30 Jun 2024 | 30 Jul 2024 | 30 days | 0001655759-24-000118 |
| 10-Q | 31 Mar 2024 | 7 May 2024 | 37 days | 0001655759-24-000060 |
| 10-K | 31 Dec 2023 | 27 Feb 2024 | 58 days | 0001655759-24-000018 |
| 10-Q | 30 Sep 2023 | 7 Nov 2023 | 38 days | 0001655759-23-000093 |
| 10-Q | 30 Jun 2023 | 8 Aug 2023 | 39 days | 0001655759-23-000079 |
| 10-Q | 31 Mar 2023 | 5 May 2023 | 35 days | 0001655759-23-000041 |
| 10-K | 31 Dec 2022 | 23 Feb 2023 | 54 days | 0001655759-23-000010 |
| 10-Q | 30 Sep 2022 | 9 Nov 2022 | 40 days | 0001655759-22-000054 |
| 10-Q | 30 Jun 2022 | 4 Aug 2022 | 35 days | 0001655759-22-000027 |
| 10-Q | 31 Mar 2022 | 5 May 2022 | 35 days | 0001655759-22-000016 |
| 10-K | 31 Dec 2021 | 28 Feb 2022 | 59 days | 0001628280-22-004262 |
| 10-Q | 30 Sep 2021 | 3 Nov 2021 | 34 days | 0001564590-21-053958 |
| 10-Q | 30 Jun 2021 | 5 Aug 2021 | 36 days | 0001564590-21-041688 |
| 10-Q | 31 Mar 2021 | 4 May 2021 | 34 days | 0001564590-21-023366 |
| 10-K | 31 Dec 2020 | 1 Mar 2021 | 60 days | 0001564590-21-009857 |
| 10-Q | 30 Sep 2020 | 5 Nov 2020 | 36 days | 0001564590-20-051413 |
| 10-Q | 30 Jun 2020 | 4 Aug 2020 | 35 days | 0001564590-20-036168 |
| 10-Q | 31 Mar 2020 | 28 Apr 2020 | 28 days | 0001564590-20-019266 |
| 10-K | 31 Dec 2019 | 16 Mar 2020 | 76 days | 0001564590-20-011004 |
| 10-Q | 30 Sep 2019 | 4 Nov 2019 | 35 days | 0001564590-19-039841 |
| 10-Q | 30 Jun 2019 | 5 Aug 2019 | 36 days | 0001564590-19-028501 |
| 10-Q | 31 Mar 2019 | 9 May 2019 | 39 days | 0001564590-19-017454 |
| 10-K | 31 Dec 2018 | 26 Mar 2019 | 85 days | 0001564590-19-009357 |
| 10-Q | 30 Sep 2018 | 14 Nov 2018 | 45 days | 0001564590-18-029393 |
Source: SEC EDGAR company submissions for CIK 0001655759. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.